| Literature DB >> 21216150 |
Varnavas D Mouchlis1, Victoria Magrioti, Efrosini Barbayianni, Nathan Cermak, Rob C Oslund, Thomas M Mavromoustakos, Michael H Gelb, George Kokotos.
Abstract
Group IIA secreted phospholipase A₂ (GIIA sPLA₂) is a member of the mammalian sPLA₂ enzyme family and is associated with various inflammatory conditions. In this study, the synthesis of 2-oxoamides based on α-amino acids and the in vitro evaluation against three secreted sPLA₂s (GIIA, GV and GX) are described. The long chain 2-oxoamide GK126 based on the amino acid (S)-leucine displayed inhibition of human and mouse GIIA sPLA₂s (IC₅₀ 300nM and 180nM, respectively). It also inhibited human GV sPLA₂ with similar potency, while it did not inhibit human GX sPLA₂. The elucidation of the stereoelectronic characteristics that affect the in vitro activity of these compounds was achieved by using a combination of simulated annealing to sample low-energy conformations before the docking procedure, and molecular docking calculations. Copyright ÂEntities:
Mesh:
Substances:
Year: 2010 PMID: 21216150 PMCID: PMC3050527 DOI: 10.1016/j.bmc.2010.12.030
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641